LLMpediaThe first transparent, open encyclopedia generated by LLMs

Genome Quebec

Generated by DeepSeek V3.2
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Expansion Funnel Raw 53 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted53
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Genome Quebec
NameGenome Quebec
Founded2000
LocationMontreal, Quebec, Canada
Key peopleDaniel Coderre (President & CEO)
FocusGenomics and personalized medicine research
Parent organizationGenome Canada
Websitehttps://www.genomequebec.com

Genome Quebec. Established in 2000, it is one of six regional genomics centers operating under the national Genome Canada network. Headquartered in Montreal, its core mission is to fund, coordinate, and promote large-scale genomics and proteomics research to drive scientific innovation and economic development within the province. The organization plays a pivotal role in advancing fields such as personalized medicine, agricultural biotechnology, and forestry genomics.

History

The organization was founded in 2000 following the launch of the national Genome Canada initiative, which was created to position Canada as a leader in the post-Human Genome Project era. Its early years were focused on building research capacity within Quebec by attracting top scientists and establishing key infrastructure, such as the McGill University and Genome Quebec Innovation Centre. A significant early milestone was its involvement in the International HapMap Project, which helped catalog human genetic variation. Over the decades, it has evolved to support increasingly complex large-scale science, from early DNA sequencing projects to contemporary integrative omics studies, responding to initiatives like the Pan-Canadian Genomics Strategy.

Organization and governance

The organization operates as an independent not-for-profit corporation governed by a Board of Directors composed of leaders from academia, industry, and the public sector. Day-to-day operations are led by a President and CEO, such as Daniel Coderre, and supported by scientific advisory committees that peer-review project proposals. It maintains a close operational relationship with its national parent, Genome Canada, while coordinating with provincial entities like the Ministère de l'Économie, de l'Innovation et de l'Énergie and the Fonds de recherche du Québec. Key internal units manage research funding, technology platforms, ethics and policy, and knowledge mobilization activities.

Research initiatives and programs

Its research portfolio is structured around major competitive funding programs, often launched in concert with Genome Canada, such as Genomics Applications Partnership Program and Large-Scale Applied Research Project competitions. These initiatives target strategic sectors including human health, where projects focus on oncology, neurodegenerative diseases, and infectious diseases like COVID-19. In the agri-food sector, programs support sustainable agriculture and animal health. Additional dedicated programs foster technology development in bioinformatics and synthetic biology, while also funding research into the ethical, environmental, economic, legal, and social aspects of genomics, known as GE3LS research.

Major projects and contributions

It has been a lead or partner in numerous high-impact international and national projects. These include significant contributions to the Canadian COVID-19 Genomics Network, which tracked variants of SARS-CoV-2. In forestry, it supported the SMarTForests Project to enhance spruce breeding. Major health initiatives have involved using genomic sequencing to diagnose rare diseases at the CHU Sainte-Justine and guiding breast cancer treatment through projects like PERSPECTIVE I&I. It also played a key role in the International Cancer Genome Consortium and the Healthy Life Trajectories Initiative, a global study on childhood development.

Partnerships and funding

Its model relies on leveraging funds from multiple partners to amplify investment in research. Primary funding comes from Genome Canada and the Government of Quebec, with significant contributions from the federal government through Innovation, Science and Economic Development Canada and the Canadian Institutes of Health Research. It actively forms consortiums with pharmaceutical companies like Pfizer, agribusiness firms, and biotechnology startups. Academic partnerships are extensive, involving all major Quebec universities, including Université de Montréal, McGill University, and Université Laval, as well as research hospitals such as the Montreal Heart Institute and the Jewish General Hospital.

Category:Genomics organizations Category:Scientific organizations based in Quebec Category:Organizations established in 2000